Ultralife Corporation

Company Profile

Ultralife Corporation had its IPO on 1992-12-23 under the ticker symbol ULBI.

The company operates in the Industrials sector and Electrical Equipment & Parts industry. Ultralife Corporation has a staff strength of 547 employees.

Stock update

Shares of Ultralife Corporation opened at $10.11 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.04 - $10.75, and closed at $10.29.

This is a +0.1% increase from the previous day's closing price.

A total volume of 268,577 shares were traded at the close of the day’s session.

In the last one week, shares of Ultralife Corporation have increased by +2.9%.

Ultralife Corporation's Key Ratios

Ultralife Corporation has a market cap of $166.03 million, indicating a price to book ratio of 0.5925 and a price to sales ratio of 0.5455.

In the last 12-months Ultralife Corporation’s revenue was $143.95 million with a gross profit of $29.40 million and an EBITDA of $8.29 million. The EBITDA ratio measures Ultralife Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Ultralife Corporation’s operating margin was 2.89% while its return on assets stood at 1.54% with a return of equity of 2.15%.

In Q2, Ultralife Corporation’s quarterly earnings growth was a positive 589.8% while revenue growth was a positive 32.9%.

Ultralife Corporation’s PE and PEG Ratio

Forward PE

16.1812

Trailing PE

68.5333

PEG

0

Its diluted EPS in the last 12-months stands at $0.15 per share while it has a forward price to earnings multiple of 16.1812 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ultralife Corporation’s profitability.

Ultralife Corporation stock is trading at a EV to sales ratio of 0.7209 and a EV to EBITDA ratio of 23.9547. Its price to sales ratio in the trailing 12-months stood at 0.5455.

Ultralife Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$175.39 million

Total Liabilities

$29.20 million

Operating Cash Flow

$-516000.00

Capital Expenditure

$516000

Dividend Payout Ratio

0%

Ultralife Corporation ended 2024 with $175.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $175.39 million while shareholder equity stood at $119.53 million.

Ultralife Corporation ended 2024 with $1.88 million in deferred long-term liabilities, $29.20 million in other current liabilities, 2059000.00 in common stock, $-44957000.00 in retained earnings and $37.50 million in goodwill. Its cash balance stood at $8.28 million and cash and short-term investments were $8.28 million. The company’s total short-term debt was $2,000,000 while long-term debt stood at $22.64 million.

Ultralife Corporation’s total current assets stands at $87.83 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $28.63 million compared to accounts payable of $18.54 million and inventory worth $46.06 million.

In 2024, Ultralife Corporation's operating cash flow was $-516000.00 while its capital expenditure stood at $516000.

Comparatively, Ultralife Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$10.29

52-Week High

$10.748

52-Week Low

$3.67

Analyst Target Price

$12

Ultralife Corporation stock is currently trading at $10.29 per share. It touched a 52-week high of $10.748 and a 52-week low of $10.748. Analysts tracking the stock have a 12-month average target price of $12.

Its 50-day moving average was $7.57 and 200-day moving average was $5.01 The short ratio stood at 0.17 indicating a short percent outstanding of 0%.

Around 420.9% of the company’s stock are held by insiders while 6532.4% are held by institutions.